The University of Southampton
University of Southampton Institutional Repository

'Jabs for the boys': time to deliver on HPV vaccination recommendations

'Jabs for the boys': time to deliver on HPV vaccination recommendations
'Jabs for the boys': time to deliver on HPV vaccination recommendations
Human papillomavirus (HPV) vaccination programmes in the UK were established in 2008, and targeted females aged 12–13 years. This decision was based on recommendations from the Joint Committee for Vaccination and Immunisation (JCVI), after assessing the available evidence for the impact and cost effectiveness of HPV vaccination programmes. The theory was that reducing HPV rates in females would result in lower infection rates in males of a similar age. This herd immunity did not extend to men-who-have-sex-with-men (MSM) or heterosexual men having sex abroad. Public Health England (PHE) undertook a trial of a targeted HPV vaccination programme for MSM in 2016–2017. The 12-month pilot involved MSM up to 45 years of age being offered Gardasil® 4, a quadrivalent HPV vaccine, through genitourinary medicine (GUM) and HIV clinics across England. GPs were not included in the pilot as there was insufficient evidence of acceptability and effective delivery. The pilot was reported as a success, and PHE has recommended rolling out this programme across England.1 The JCVI issued an interim statement regarding extending HPV immunisation to adolescent males in July 2017, again concluding that there was insufficient evidence for benefit in males.2 However, after strong responses through stakeholder consultations, continued pressure from lobby groups such as HPV Action (www.hpvaction.org), and further analysis of the latest research, the JCVI recently (18 July 2018) recommended extending the HPV vaccination programme to adolescent males.3
0960-1643
406-407
Merriel, Samuel W.D.
50082f10-4f74-4fea-8ef4-919a0ed4b6a3
Nadarzynski, Tom
218d69a1-d1be-46f4-bead-23071bd4f270
Kesten, Joanna M.
d76376a3-d948-4ae3-8057-00898a21a5fb
Flannagan, Carrie
227e877d-af85-4556-8f39-8b9c6e2f2fec
Prue, Gillian
abe27453-2116-45d6-b012-9f448fde05b1
Merriel, Samuel W.D.
50082f10-4f74-4fea-8ef4-919a0ed4b6a3
Nadarzynski, Tom
218d69a1-d1be-46f4-bead-23071bd4f270
Kesten, Joanna M.
d76376a3-d948-4ae3-8057-00898a21a5fb
Flannagan, Carrie
227e877d-af85-4556-8f39-8b9c6e2f2fec
Prue, Gillian
abe27453-2116-45d6-b012-9f448fde05b1

Merriel, Samuel W.D., Nadarzynski, Tom, Kesten, Joanna M., Flannagan, Carrie and Prue, Gillian (2018) 'Jabs for the boys': time to deliver on HPV vaccination recommendations. British Journal of General Practice, 68 (674), 406-407. (doi:10.3399/bjgp18X698429).

Record type: Editorial

Abstract

Human papillomavirus (HPV) vaccination programmes in the UK were established in 2008, and targeted females aged 12–13 years. This decision was based on recommendations from the Joint Committee for Vaccination and Immunisation (JCVI), after assessing the available evidence for the impact and cost effectiveness of HPV vaccination programmes. The theory was that reducing HPV rates in females would result in lower infection rates in males of a similar age. This herd immunity did not extend to men-who-have-sex-with-men (MSM) or heterosexual men having sex abroad. Public Health England (PHE) undertook a trial of a targeted HPV vaccination programme for MSM in 2016–2017. The 12-month pilot involved MSM up to 45 years of age being offered Gardasil® 4, a quadrivalent HPV vaccine, through genitourinary medicine (GUM) and HIV clinics across England. GPs were not included in the pilot as there was insufficient evidence of acceptability and effective delivery. The pilot was reported as a success, and PHE has recommended rolling out this programme across England.1 The JCVI issued an interim statement regarding extending HPV immunisation to adolescent males in July 2017, again concluding that there was insufficient evidence for benefit in males.2 However, after strong responses through stakeholder consultations, continued pressure from lobby groups such as HPV Action (www.hpvaction.org), and further analysis of the latest research, the JCVI recently (18 July 2018) recommended extending the HPV vaccination programme to adolescent males.3

Full text not available from this repository.

More information

Accepted/In Press date: 30 August 2018
e-pub ahead of print date: 30 August 2018
Published date: 1 September 2018

Identifiers

Local EPrints ID: 424209
URI: http://eprints.soton.ac.uk/id/eprint/424209
ISSN: 0960-1643
PURE UUID: 9e7bfb91-0303-47da-8cf9-4373c3e7055e

Catalogue record

Date deposited: 05 Oct 2018 11:34
Last modified: 07 Oct 2020 00:57

Export record

Altmetrics

Contributors

Author: Samuel W.D. Merriel
Author: Tom Nadarzynski
Author: Joanna M. Kesten
Author: Carrie Flannagan
Author: Gillian Prue

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×